{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:05:18Z","timestamp":1783998318258,"version":"3.55.0"},"reference-count":14,"publisher":"International Union Against Tuberculosis and Lung Disease","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJTLD Open"],"accepted":{"date-parts":[[2026,4,18]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>TB remains a major public health challenge in the Kyrgyz Republic due to continued transmission and drug resistance. Despite an overall decline in incidence, gaps persist in case notification, procurement processes, and patient-centred care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This study reports on the first community-led monitoring (CLM) initiative for TB services, implemented by TB People Kyrgyzstan in partnership with KNCV KG from 2019 to 2024. Programmatic data were combined with structured interviews of people with TB, community monitors, and health workers to identify barriers to diagnosis, treatment, and access to medicines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Estimated TB incidence declined over the study period, yet under-notification remained substantial, with 56.5% of cases not notified in 2024. Procurement was generally stable; however, regulatory and customs delays limited access to new medicines. Patients reported stigma, transport costs, and limited psychosocial support as key barriers, while health workers highlighted shortages of trained staff in rural areas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>CLM complemented national surveillance by amplifying community perspectives and identifying actionable priorities. Expanding access to rapid diagnostics, strengthening procurement coordination, investing in the TB workforce, and sustaining community engagement are essential to accelerate progress towards End TB targets. This approach supports equity, improvement, and resilience.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5588\/ijtldopen.25.0691","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:34:44Z","timestamp":1783996484000},"page":"461-465","source":"Crossref","is-referenced-by-count":0,"title":["Community-led monitoring of TB services in the Kyrgyz Republic"],"prefix":"10.5588","volume":"3","author":[{"given":"B.","family":"Myrzaliev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Palastrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ahmatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Igolnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kadyrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3554","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2026071319343570000_3.7.461.1","unstructured":"World Health Organization . Global tuberculosis report 2024. Geneva: WHO, 2024."},{"key":"2026071319343570000_3.7.461.2","unstructured":"National Statistics Committee of the Kyrgyz Republic . Health and demographic indicators 2023. Bishkek, Kyrgyzstan: NatStatCom, 2024."},{"key":"2026071319343570000_3.7.461.3","unstructured":"Ministry of Health of the Kyrgyz Republic, National TB Program . Annual TB Report 2023. Bishkek, Kyrgyzstan: MoH, 2024."},{"key":"2026071319343570000_3.7.461.4","unstructured":"Stop TB Partnership . Community, rights and gender strategic initiative: community-led monitoring for accountability in TB response. Geneva: Stop, 2020."},{"key":"2026071319343570000_3.7.461.5","unstructured":"The Global Fund . COPPER Community-Led Monitoring Initiative. 2025. https:\/\/www.globalsouthopportunities.com\/2025\/03\/14\/funding-alert-copper-clm-esearch295grants-available\/#google_vignette (Accessed 20 May 2025)."},{"key":"2026071319343570000_3.7.461.6","unstructured":"KNCV Tuberculosis Foundation . Community-led monitoring methodology: adaptation for the 297 Kyrgyz Republic. Internal report. Bishkek, Kyrgyzstan: KNCV KG, 2024."},{"issue":"6","key":"2026071319343570000_3.7.461.7","first-page":"1901467","article-title":"Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis","volume":"54","author":"Abidi","year":"2019","journal-title":"Eur Respir J"},{"key":"2026071319343570000_3.7.461.8","unstructured":"Challenge TB . Request for proposals for sub-award registration of second line drugs. Washington DC, USA: Challenge TB, 2018. https:\/\/challengetb.org\/wp-ontent\/uploads\/2018\/01\/RFA_Kyrgyzstan_Second_Line_Drugs.pdf."},{"key":"2026071319343570000_3.7.461.9","unstructured":"Kyrgyzstan UNDP . I believe in life again: how UNDP helps to fight against tuberculosis in Kyrgyzstan. Bishkek, Kyrgyzstan. UNDP, 2023. https:\/\/www.undp.org\/kyrgyzstan\/stories\/i-believe-life-again-how-undp-helps-fight-against307tuberculosis-kyrgyzstan."},{"key":"2026071319343570000_3.7.461.10","unstructured":"USP JSI . Reflecting on results from four years fighting TB in Kyrgyz Republic. Rockville, MD: United States Pharmacopeia\/JSI, 2023. https:\/\/qualitymatters.usp.org\/reflectingresults-four-years-fighting-tb-kyrgyz-republic."},{"key":"2026071319343570000_3.7.461.11","unstructured":"Pereboi.kg . Community reporting platform for medicine and diagnostic shortages in Kyrgyz Republic. Bishkek, Kyrgyzstan: Pereboi.net, 2023\u20132025. https:\/\/pereboi.kg\/ ."},{"key":"2026071319343570000_3.7.461.12","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.jctube.2024.100472","article-title":"Experiences in the introduction of bedaquiline, pretomanid, and linezolid for drug-resistant tuberculosis in Kyrgyz Republic","volume":"36","author":"Myrzaliev","year":"2024","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"2026071319343570000_3.7.461.13","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1186\/s12889-021-11427-y","article-title":"Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen","volume":"21","author":"van de Berg","year":"2021","journal-title":"BMC Public Health"},{"key":"2026071319343570000_3.7.461.14","unstructured":"Burnet Institute . Evaluating cost-effective investments to reduce the burden of drug-resistant tuberculosis in Kyrgyz Republic. Melbourne, Australia: Burnet Institute, 2021."}],"container-title":["IJTLD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.5588\/ijtldopen.25.0691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:34:46Z","timestamp":1783996486000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.theunion.org\/lookup\/doi\/10.5588\/ijtldopen.25.0691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":14,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.5588\/ijtldopen.25.0691"],"URL":"https:\/\/doi.org\/10.5588\/ijtldopen.25.0691","relation":{},"ISSN":["3005-7590"],"issn-type":[{"value":"3005-7590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}